Tutorial
Robinhood Chain
…
Wallet
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Telegram alerts
Tutorial
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Alerts on Telegram
Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram
Overview
Follow the Money
Daily Brief
Live
Congress
Directory
Corporate Insiders
Planned Sales & Stakes
Government Money
Political Influence
Institutions
Washington Network
Follow the Power
Disclosure Clock
AI Investigator
Watchlist
Convergence
INSIDER Alpha
Signal ledger
Historical Replay
Robinhood Chain
Proof
Trading
Token
Pro
Account
Methodology
Telegram alerts
Tutorial
PALISADE BIO, INC. (PALI) · INSIDER
Data sources
SEC Form 4
4h ago
House PTR
4h ago
SEC 13F
4h ago
Robinhood Chain
4h ago
Public company
PALISADE BIO, INC.
PALI
CIK 0001357459
EDGAR filings
Open in network
○
Watch PALI
Price
$1.14
1 year
-32.1%
Disclosed transactions
1
Buys / sells
0 / 0
Max Insider Score
9
Connections with evidence
4
Customize layout
PALI · disclosed activity on price
Disclosed transactions
Score
Actor
Security
Side
Value
Executed
Disclosed
Lag
Source
Evidence
9
CE
Capers Julien E.
See Remarks
PALI
PALISADE BIO, INC.
Grant or award
A
—
787.3K sh
Oct 19, 2026
Oct 21, 2026
Verified connections
← Holds over 5% of
evidence
Soleus Capital Master Fund, L.P.
8.6% of class · Schedule 13G · Nov 8, 2026
In industry
evidence
Pharmaceuticals, devices & health services
SEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
← Holds over 5% of
evidence
Vanguard Capital Management
5.16% of class · Schedule 13G · Oct 29, 2026
← Insider of
evidence
Capers Julien E.
See Remarks · Oct 21, 2026
traded Oct 19, 2026
+2d
SEC Form 4
Evidence
Evidence
Close
Disclosed trades
TradingView
Planned sales and 5% stakes
Form 144, 13D and 13G
SP
Soleus Capital Master Fund, L.P.
Passive holder · crossed on Sep 30, 2026 · 15.00M shares
8.6% of class
13G amendment · filed Nov 9, 2026
VM
Vanguard Capital Management
Passive holder · crossed on Sep 30, 2026 · 9.00M shares
5.16% of class
13G · filed Oct 30, 2026